Scarica l'app Stockscreener
4.65
3.91%
-0.21
Precedente Chiudi:
$4.86
Aprire:
$4.86
Volume 24 ore:
511.06K
Relative Volume:
0.44
Capitalizzazione di mercato:
$595.21M
Reddito:
$193.01M
Utile/perdita netta:
$-12.15M
Rapporto P/E:
-51.67
EPS:
-0.09
Flusso di cassa netto:
$454.00K
1 W Prestazione:
-3.91%
1M Prestazione:
-15.09%
6M Prestazione:
+45.03%
1 anno Prestazione:
-24.80%
Intervallo 1D:
$4.645
$4.905
Intervallo di 1 settimana:
$4.6719
$5.1642
Portata 52W:
$2.37
$7.30
Cytek Biosciences Inc Stock (CTKB) Company Profile
Nome
Cytek Biosciences Inc
Settore
Industria
Telefono
(877) 922-9835
Indirizzo
47215 LAKEVIEW BOULEVARD, FREMONT
Confronta CTKB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
4.655 | 621.42M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
128.60 | 218.16B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.05 | 137.24B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
352.77 | 135.41B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
98.81 | 128.03B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.59 | 48.21B | 5.88B | 1.34B | 799.60M | 2.3489 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Equal-Weight |
| 2025-05-09 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-31 | Downgrade | Goldman | Buy → Sell |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-07-19 | Iniziato | Raymond James | Mkt Perform |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
Mostra tutto
Cytek Biosciences Inc Borsa (CTKB) Ultime notizie
Cytek BioSciences Inc (CTKB) expanding its growth trajectory ahead - Setenews
Why Cytek Biosciences Inc. (8EQ) stock stays on buy listsQuarterly Portfolio Report & High Accuracy Buy Signal Tips - Newser
Institutional Owners May Consider Drastic Measures as Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Recent US$58m Drop Adds to Long-term Losses - 富途牛牛
Brown Capital Management LLC Has $24.17 Million Stock Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
Is Cytek Biosciences Inc. stock overvalued by current metricsJuly 2025 EndofMonth & Precise Entry and Exit Recommendations - Newser
Can Cytek Biosciences Inc. stock beat market expectations this quarter - Newser
Can Cytek Biosciences Inc. (8EQ) stock sustain revenue momentumGDP Growth & Safe Capital Growth Plans - Newser
Why Cytek Biosciences Inc. stock attracts global investorsWeekly Trend Report & Fast Gain Stock Tips - Newser
Can Cytek Biosciences Inc. stock maintain operating marginsEarnings Growth Summary & Entry Point Strategy Guides - Newser
Is Cytek Biosciences Inc. (8EQ) stock attractive for dividend growthJuly 2025 Sentiment & Community Verified Trade Alerts - Newser
What is Cytek BioSciences Inc (CTKB) Stock Return on Shareholders’ Capital? - setenews.com
Tranche Update on Cytek Biosciences, Inc.'s Equity Buyback Plan announced on December 30, 2024. - marketscreener.com
Will Cytek Biosciences Inc. (8EQ) stock draw ESG focused funds2025 Fundamental Recap & AI Driven Stock Price Forecasts - Newser
Morgan Stanley Raises Price Target on Cytek Biosciences to $6 From $4, Keeps Equalweight Rating - marketscreener.com
Cytek Biosciences (CTKB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Published on: 2025-12-02 04:27:45 - Newser
What dividend safety score for Cytek Biosciences Inc. stockPortfolio Profit Report & Long-Term Safe Investment Ideas - moha.gov.vn
Check out these key findings about Cytek BioSciences Inc (CTKB) - Setenews
Bank of Montreal Can Boosts Stock Position in Cytek Biosciences, Inc. $CTKB - Defense World
Revenues Tell The Story For Cytek Biosciences, Inc. (NASDAQ:CTKB) As Its Stock Soars 43% - simplywall.st
Cytek Biosciences (NASDAQ:CTKB) Stock Price Up 7.2%Here's What Happened - MarketBeat
[Form 4] Cytek Biosciences, Inc. Insider Trading Activity - Stock Titan
Officer/Dir Yan Acquires 15,908 Of Cytek BioSciences Inc [CTKB] - TradingView
Why Cytek Biosciences Inc. stock could be next big winnerJuly 2025 Update & AI Driven Stock Reports - newser.com
Is Cytek Biosciences Inc. (8EQ) stock a good hedge against inflationJuly 2025 Summary & High Conviction Buy Zone Alerts - newser.com
Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth (CTKB) - Seeking Alpha
What technical charts say about Cytek Biosciences Inc. stockJuly 2025 Patterns & Reliable Momentum Entry Alerts - newser.com
Cytek Biosciences, Inc. (CTKB) Stock Forecasts - Yahoo! Finance Canada
Why Cytek Biosciences Inc. (8EQ) stock is favored by hedge fundsAnalyst Upgrade & Daily Oversold Stock Bounce Ideas - newser.com
Check Out Cytek BioSciences Inc (CTKB)’s Trade Data Rather Than the Analysts’ Views - Setenews
What technical models suggest about Cytek Biosciences Inc.’s comeback - newser.com
Can Cytek Biosciences Inc. stock maintain growth trajectoryTrade Performance Summary & Free Real-Time Market Sentiment Alerts - newser.com
Does TIME Recognition Signal a Turning Point for Cytek Biosciences' (CTKB) Competitive Edge in Innovation? - Yahoo Finance
Cytek Biosciences Inc Azioni (CTKB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cytek Biosciences Inc Azioni (CTKB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| McCombe William D. | Chief Financial Officer |
Jun 02 '25 |
Buy |
2.78 |
35,000 |
97,300 |
55,746 |
0.29%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):